After generating over 10 million social media impressions with the launch of its text-to-3D model app, Adam has raised a $4.1 ...
Altimmune continues developing pemvidutide for MASH but has yet to secure a partner or acquisition despite sector M&A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback